Key Insights

Highlights

Treatment Research

4 treatments under study, led by Lactobacillus Rhamnosus

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 1/2 (1)

Trial Status

Unknown2

Clinical Trials (2)

Showing 2 of 2 trials
NCT06268964Phase 1/2Unknown

Exploring Treatments for Children's Abdominal Pain: Comparing Trimebutine and Probiotics

NCT04890405Not ApplicableUnknownPrimary

Clinical Study of Selective Fecal Microbiota Transplantation in the Treatment of Irritable Bowel Syndrome.

Showing all 2 trials

Research Network

Common Treatments

  • Lactobacillus Rhamnosus1
  • Precision Flora Transplantation1
  • Trimebutine1
  • Standardized Fmt1

Active Sponsors

  • Universidad de Colima1
  • Yanling Wei1

Top Investigators

Related Conditions

  • Functional Abdominal Pain Syndrome1
  • Functional Gastrointestinal Disorders1

Activity Timeline